Atopic dermatitis, which many people call eczema, and contact dermatitis are often confused due to their similar symptoms. However, a person inherits atopic dermatitis, while contact dermatitis ...

The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

#skindisease #globaldata’ The report reveals atopic dermatitis cases, also known as eczema, are rising because of the ...

Self-guided cognitive behavioral therapy (CBT) proved noninferior to clinician-guided CBT for reducing symptom severity in ...

In a subset of patients in a 48-week extension trial, the mean duration of the first treatment-free interval was ...

The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-sev ...

JAK inhibitors approved for atopic dermatitis/eczema include Opzelura (Ruxolitinib), or Rinvoq (Upadacitinib). Vtama cream (tapinarof) is a once-daily steroid-free treatment approved to treat ...

The global prevalence of atopic dermatitis -- a chronic skin condition -- is expected to reach 42.42 million by 2033, ...

When 30-year-old Eve (not her real name) gave birth to her baby son, Luke (not his real name), in early 2024, she knew she ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...

The US Food and Drug Administration (FDA) has approved Vtama (tapinarof) cream 1%, an aryl hydrocarbon receptor agonist, for ...